NCT05873751View on ClinicalTrials.gov

A Study to Learn About How Trumenba Vaccine Shots Work Against Gonorrhea Infection in Teenagers and Young Adults in the United States.

CompletedOBSERVATIONAL
Enrollment

1,307,378

Participants

Timeline

Start Date

April 24, 2023

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2024

Conditions
GonorrheaChlamydiaMeningococcal Vaccines
Interventions
BIOLOGICAL

Trumenba Vaccine

Trumenba vaccine given as standard of care

BIOLOGICAL

MenACWY Vaccine

MenACWY Vaccine given as standard of care

Trial Locations (1)

10001

Pfizer, New York

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT05873751 - A Study to Learn About How Trumenba Vaccine Shots Work Against Gonorrhea Infection in Teenagers and Young Adults in the United States. | Biotech Hunter | Biotech Hunter